Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

1. Bellmunt, J.
2. Albanell, J.
3. Paz-Ares, L.
4. Climent, M.A.
5. González-Larriba, J.L.
6. Carles, J.
7. De La Cruz, J.J.
8. Guillem, V.
9. Díaz-Rubio, E.
10. Cortés-Funes, H.
11. Baselga, J.